C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/00 (2006.01) C07H 21/04 (2006.01) C12Q 1/42 (2006.01)
Patent
CA 2527853
Human MPTEN genes are identified as modulators of the PTEN/IGF pathway, and thus are therapeutic targets for disorders associated with defective PTEN/IGF function. Methods for identifying modulators of PTEN/IGF, comprising screening for agents that modulate the activity of MPTEN are provided.
Selon l'invention, des gènes MPTEN humains ont été identifiés en tant que modulateurs du passage PTEN/IGF, et sont ainsi des cibles thérapeutiques pour des troubles liés à une déficience de la fonction PTEN/IGF. L'invention a également pour objet des procédés pour identifier des modulateurs de PTEN/IGF, comprenant des agents qui modulent l'activité de MPTEN.
Costa Michael R.
Lickteig Kim
Mcgrath Garth Joseph
Bennett Jones Llp
Exelixis Inc.
LandOfFree
Mptens as modifiers of the pten/igf pathway and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mptens as modifiers of the pten/igf pathway and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mptens as modifiers of the pten/igf pathway and methods of use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1876160